Literature DB >> 15960866

Peptide YY, appetite and food intake.

C W le Roux1, S R Bloom.   

Abstract

Obesity is taking on pandemic proportions. The laws of thermodynamics, however, remain unchanged, as energy will be stored if less energy is expended than consumed; the storage is usually in the form of adipose tissue. Several neural, humeral and psychological factors control the complex process known as appetite. Recently, a close evolutionary relationship between the gut and brain has become apparent. The gut hormones regulate important gastrointestinal functions such as motility, secretion, absorption, provide feedback to the central nervous system on availability of nutrients and may play a part in regulating food intake. Peptide YY (PYY) is a thirty-six amino acid peptide related to neuropeptide Y (NPY) and is co-secreted with glucagon-like peptide 1. Produced by the intestinal L-cells, the highest tissue concentrations of PYY are found in distal segments of the gastrointestinal tract, although it is present throughout the gut. Following food intake PYY is released into the circulation. PYY concentrations are proportional to meal energy content and peak plasma levels appear postprandially after 1 h. PYY3-36 is a major form of PYY in both the gut mucosal endocrine cells and the circulation. Peripheral administration of PYY3-36 inhibits food intake for several hours in both rodents and man. The binding of PYY3-36 to the Y2 receptor leads to an inhibition of the NPY neurones and a possible reciprocal stimulation of the pro-opiomelanocortin neurones. Thus, PYY3-36 appears to control food intake by providing a powerful feedback on the hypothalamic circuits. The effect on food intake has been demonstrated at physiological concentrations and, therefore, PYY3-36 may be important in the everyday regulation of food intake.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15960866     DOI: 10.1079/pns2005427

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  28 in total

1.  Polymorphisms in LEP and NPY genes modify the response to soluble fibre Plantago ovata husk intake on cardiovascular risk biomarkers.

Authors:  Anna Crescenti; Rosa Solà; Rosa M Valls; Anna Anguera; Lluís Arola
Journal:  Genes Nutr       Date:  2012-06-06       Impact factor: 5.523

Review 2.  The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity.

Authors:  Christopher N Ochner; Charlisa Gibson; Susan Carnell; Carl Dambkowski; Allan Geliebter
Journal:  Physiol Behav       Date:  2010-05-08

3.  Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication.

Authors:  J Miholic; M Hoffmann; J J Holst; J Lenglinger; M Mittlböck; H Bergmann; G Stacher
Journal:  Surg Endosc       Date:  2007-01-02       Impact factor: 4.584

4.  Obesity and the gut microbiome: Striving for causality.

Authors:  Isaac T W Harley; Christopher L Karp
Journal:  Mol Metab       Date:  2012-08-03       Impact factor: 7.422

Review 5.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 6.  Changes in neurohormonal gut peptides following bariatric surgery.

Authors:  C N Ochner; C Gibson; M Shanik; V Goel; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2010-07-13       Impact factor: 5.095

Review 7.  Physiology of weight loss surgery.

Authors:  Chan W Park; Alfonso Torquati
Journal:  Surg Clin North Am       Date:  2011-12       Impact factor: 2.741

8.  Ghrelin and peptide YY in postpartum lactating and nonlactating women.

Authors:  D Enette Larson-Meyer; Eric Ravussin; Leonie Heilbronn; Lilian DeJonge
Journal:  Am J Clin Nutr       Date:  2009-12-09       Impact factor: 7.045

9.  Pilot Study Measuring the Novel Satiety Hormone, Pro-Uroguanylin, in Adolescents With and Without Obesity.

Authors:  Matthew D Di Guglielmo; Dalal Tonb; Zhaoping He; Adebowale Adeyemi; Kenneth L van Golen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-03       Impact factor: 2.839

10.  A bitter pill for type 2 diabetes? The activation of bitter taste receptor TAS2R38 can stimulate GLP-1 release from enteroendocrine L-cells.

Authors:  Hung Pham; Hongxiang Hui; Susan Morvaridi; Jiena Cai; Sanqi Zhang; Jun Tan; Vincent Wu; Nancy Levin; Beatrice Knudsen; William A Goddard; Stephen J Pandol; Ravinder Abrol
Journal:  Biochem Biophys Res Commun       Date:  2016-05-18       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.